APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Drug Delivery Technology

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nasal Drug Delivery Technology Industry Growth and Trends Forecast to 2032

22 December 2025112 pages

Choose your research edition.

Industry ResearchNasal Drug Delivery Technology Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Drug Delivery Technology Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Nasal Drug Delivery Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Drug Delivery Technology Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Drug Delivery Technology Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

According to APO Research, the global Nasal Drug Delivery Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nasal Drug Delivery Technology market include Johnson & Johnson, Novartis AG, Merck & Co., Inc., Pfizer, Inc, Shin Nippon Biomedical Laboratories, Promius Pharma, LLC, PendoPharm, Inc, OptiNose, Inc and Glaxosmithkline PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nasal Drug Delivery Technology market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nasal Drug Delivery Technology market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nasal Drug Delivery Technology market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nasal Drug Delivery Technology.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nasal Drug Delivery Technology market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nasal Drug Delivery Technology Market by Company

Johnson & Johnson

Novartis AG

Merck & Co., Inc.

Pfizer, Inc

Shin Nippon Biomedical Laboratories

Promius Pharma, LLC

PendoPharm, Inc

OptiNose, Inc

Glaxosmithkline PLC

ENT Technologies Pty. Ltd

Douglas Pharmaceuticals Ltd

Dickinson and Company

Cadila Pharmaceuticals Ltd

BF Ascher & Company, Inc.

Becton, Dickinson and Company

Aptargroup, Inc.

Aegis Therapeutics LLC

3M United States

Nasal Drug Delivery Technology Segment by Type

Pressurized Type

Non-pressurized Type

Nasal Drug Delivery Technology Segment by Application

Asthma

Rhinitis

Nasal Congestion

Other

Nasal Drug Delivery Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Drug Delivery Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Drug Delivery Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Drug Delivery Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nasal Drug Delivery Technology companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nasal Drug Delivery Technology Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nasal Drug Delivery Technology Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nasal Drug Delivery Technology Market Share by Region (2021-2026) Table 4. Global Nasal Drug Delivery Technology Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nasal Drug Delivery Technology Market Share by Region (2027-2032) Table 6. Global Nasal Drug Delivery Technology Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nasal Drug Delivery Technology Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nasal Drug Delivery Technology Market Size Share by Type (2021-2026) Table 9. Global Nasal Drug Delivery Technology Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nasal Drug Delivery Technology Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nasal Drug Delivery Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nasal Drug Delivery Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nasal Drug Delivery Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nasal Drug Delivery Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nasal Drug Delivery Technology Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nasal Drug Delivery Technology Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nasal Drug Delivery Technology Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nasal Drug Delivery Technology Market Size Share by Application (2021-2026) Table 24. Global Nasal Drug Delivery Technology Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nasal Drug Delivery Technology Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nasal Drug Delivery Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nasal Drug Delivery Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nasal Drug Delivery Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nasal Drug Delivery Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nasal Drug Delivery Technology Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nasal Drug Delivery Technology Industry Trends Table 37. Nasal Drug Delivery Technology Industry Drivers Table 38. Nasal Drug Delivery Technology Industry Opportunities and Challenges Table 39. Nasal Drug Delivery Technology Industry Restraints Table 40. Global Nasal Drug Delivery Technology Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nasal Drug Delivery Technology Revenue Market Share by Company (2021-2026) Table 42. Global Nasal Drug Delivery Technology Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nasal Drug Delivery Technology Key Company Headquarters & Area Served Table 44. Global Nasal Drug Delivery Technology Company, Product Type & Application Table 45. Global Nasal Drug Delivery Technology Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nasal Drug Delivery Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Johnson & Johnson Company Information Table 49. Johnson & Johnson Business Overview Table 50. Johnson & Johnson Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Johnson & Johnson Nasal Drug Delivery Technology Product Portfolio Table 52. Johnson & Johnson Recent Development Table 53. Novartis AG Company Information Table 54. Novartis AG Business Overview Table 55. Novartis AG Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis AG Nasal Drug Delivery Technology Product Portfolio Table 57. Novartis AG Recent Development Table 58. Merck & Co., Inc. Company Information Table 59. Merck & Co., Inc. Business Overview Table 60. Merck & Co., Inc. Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Merck & Co., Inc. Nasal Drug Delivery Technology Product Portfolio Table 62. Merck & Co., Inc. Recent Development Table 63. Pfizer, Inc Company Information Table 64. Pfizer, Inc Business Overview Table 65. Pfizer, Inc Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer, Inc Nasal Drug Delivery Technology Product Portfolio Table 67. Pfizer, Inc Recent Development Table 68. Shin Nippon Biomedical Laboratories Company Information Table 69. Shin Nippon Biomedical Laboratories Business Overview Table 70. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Portfolio Table 72. Shin Nippon Biomedical Laboratories Recent Development Table 73. Promius Pharma, LLC Company Information Table 74. Promius Pharma, LLC Business Overview Table 75. Promius Pharma, LLC Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Promius Pharma, LLC Nasal Drug Delivery Technology Product Portfolio Table 77. Promius Pharma, LLC Recent Development Table 78. PendoPharm, Inc Company Information Table 79. PendoPharm, Inc Business Overview Table 80. PendoPharm, Inc Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. PendoPharm, Inc Nasal Drug Delivery Technology Product Portfolio Table 82. PendoPharm, Inc Recent Development Table 83. OptiNose, Inc Company Information Table 84. OptiNose, Inc Business Overview Table 85. OptiNose, Inc Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. OptiNose, Inc Nasal Drug Delivery Technology Product Portfolio Table 87. OptiNose, Inc Recent Development Table 88. Glaxosmithkline PLC Company Information Table 89. Glaxosmithkline PLC Business Overview Table 90. Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Glaxosmithkline PLC Nasal Drug Delivery Technology Product Portfolio Table 92. Glaxosmithkline PLC Recent Development Table 93. ENT Technologies Pty. Ltd Company Information Table 94. ENT Technologies Pty. Ltd Business Overview Table 95. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Portfolio Table 97. ENT Technologies Pty. Ltd Recent Development Table 98. Douglas Pharmaceuticals Ltd Company Information Table 99. Douglas Pharmaceuticals Ltd Business Overview Table 100. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio Table 102. Douglas Pharmaceuticals Ltd Recent Development Table 103. Dickinson and Company Company Information Table 104. Dickinson and Company Business Overview Table 105. Dickinson and Company Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Dickinson and Company Nasal Drug Delivery Technology Product Portfolio Table 107. Dickinson and Company Recent Development Table 108. Cadila Pharmaceuticals Ltd Company Information Table 109. Cadila Pharmaceuticals Ltd Business Overview Table 110. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio Table 112. Cadila Pharmaceuticals Ltd Recent Development Table 113. BF Ascher & Company, Inc. Company Information Table 114. BF Ascher & Company, Inc. Business Overview Table 115. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Portfolio Table 117. BF Ascher & Company, Inc. Recent Development Table 118. Becton, Dickinson and Company Company Information Table 119. Becton, Dickinson and Company Business Overview Table 120. Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Becton, Dickinson and Company Nasal Drug Delivery Technology Product Portfolio Table 122. Becton, Dickinson and Company Recent Development Table 123. Aptargroup, Inc. Company Information Table 124. Aptargroup, Inc. Business Overview Table 125. Aptargroup, Inc. Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Aptargroup, Inc. Nasal Drug Delivery Technology Product Portfolio Table 127. Aptargroup, Inc. Recent Development Table 128. Aegis Therapeutics LLC Company Information Table 129. Aegis Therapeutics LLC Business Overview Table 130. Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Portfolio Table 132. Aegis Therapeutics LLC Recent Development Table 133. 3M United States Company Information Table 134. 3M United States Business Overview Table 135. 3M United States Nasal Drug Delivery Technology Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. 3M United States Nasal Drug Delivery Technology Product Portfolio Table 137. 3M United States Recent Development Table 138. North America Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Nasal Drug Delivery Technology Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Nasal Drug Delivery Technology Market Share by Country (2021-2026) Table 141. North America Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Nasal Drug Delivery Technology Market Share Forecast by Country (2027-2032) Table 143. Europe Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Nasal Drug Delivery Technology Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Nasal Drug Delivery Technology Market Share by Country (2021-2026) Table 146. Europe Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Nasal Drug Delivery Technology Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Nasal Drug Delivery Technology Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Nasal Drug Delivery Technology Market Share by Country (2021-2026) Table 151. Asia-Pacific Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Nasal Drug Delivery Technology Market Share Forecast by Country (2027-2032) Table 153. Latin America Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Nasal Drug Delivery Technology Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Nasal Drug Delivery Technology Market Share by Country (2021-2026) Table 156. Latin America Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Nasal Drug Delivery Technology Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Nasal Drug Delivery Technology Market Share by Country (2021-2026) Table 161. Middle East & Africa Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Nasal Drug Delivery Technology Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nasal Drug Delivery Technology Product Image Figure 3. Global Nasal Drug Delivery Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 5. Global Nasal Drug Delivery Technology Market Share by Region: 2025 VS 2032 Figure 6. Global Nasal Drug Delivery Technology Market Share by Region (2021-2032) Figure 7. North America Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Pressurized Type Image Figure 13. Global Pressurized Type Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-pressurized Type Image Figure 15. Global Non-pressurized Type Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Nasal Drug Delivery Technology Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Nasal Drug Delivery Technology Market Share by Type 2025 VS 2032 Figure 18. North America Nasal Drug Delivery Technology Market Size Share by Type (2021-2032) Figure 19. Europe Nasal Drug Delivery Technology Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Nasal Drug Delivery Technology Market Size Share by Type (2021-2032) Figure 21. Latin America Nasal Drug Delivery Technology Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Nasal Drug Delivery Technology Market Size Share by Type (2021-2032) Figure 23. Asthma Image Figure 24. Global Asthma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Rhinitis Image Figure 26. Global Rhinitis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Nasal Congestion Image Figure 28. Global Nasal Congestion Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Nasal Drug Delivery Technology Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Nasal Drug Delivery Technology Market Share by Application 2025 VS 2032 Figure 33. North America Nasal Drug Delivery Technology Market Size Share by Application (2021-2032) Figure 34. Europe Nasal Drug Delivery Technology Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Nasal Drug Delivery Technology Market Size Share by Application (2021-2032) Figure 36. Latin America Nasal Drug Delivery Technology Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Nasal Drug Delivery Technology Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Nasal Drug Delivery Technology Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Nasal Drug Delivery Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Nasal Drug Delivery Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 43. Europe Nasal Drug Delivery Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Nasal Drug Delivery Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 46. Asia-Pacific Nasal Drug Delivery Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Nasal Drug Delivery Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 49. Latin America Nasal Drug Delivery Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Nasal Drug Delivery Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 52. Middle East & Africa Nasal Drug Delivery Technology Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Nasal Drug Delivery Technology Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Pressurized Type
  • Non-pressurized Type
Applications
  • Asthma
  • Rhinitis
  • Nasal Congestion
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co., Inc.
  • Pfizer, Inc
  • Shin Nippon Biomedical Laboratories
  • Promius Pharma, LLC
  • PendoPharm, Inc
  • OptiNose, Inc
  • Glaxosmithkline PLC
  • ENT Technologies Pty. Ltd
  • Douglas Pharmaceuticals Ltd
  • Dickinson and Company
  • Cadila Pharmaceuticals Ltd
  • BF Ascher & Company, Inc.
  • Becton, Dickinson and Company
  • Aptargroup, Inc.
  • Aegis Therapeutics LLC
  • 3M United States

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nasal Drug Delivery Technology Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nasal Drug Delivery Technology Market Size by Region (2021-2032)
  5. 1.4.1 Global Nasal Drug Delivery Technology Market Size by Region (2021-2026)
  6. 1.4.2 Global Nasal Drug Delivery Technology Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nasal Drug Delivery Technology Market Size (2021-2032)
  8. 1.5.1 North America Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nasal Drug Delivery Technology Market Size Growth Rate (2021-2032)
2 Nasal Drug Delivery Technology Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Pressurized Type
  3. 2.1.2 Non-pressurized Type
  4. 2.2 Global Nasal Drug Delivery Technology Market Size by Type
  5. 2.2.1 Global Nasal Drug Delivery Technology Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Nasal Drug Delivery Technology Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Nasal Drug Delivery Technology Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Nasal Drug Delivery Technology Market Size by Regions
  9. 2.3.1 North America Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Nasal Drug Delivery Technology Market Size Breakdown by Type (2021-2026)
3 Nasal Drug Delivery Technology Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Asthma
  3. 3.1.2 Rhinitis
  4. 3.1.3 Nasal Congestion
  5. 3.1.4 Other
  6. 3.2 Global Nasal Drug Delivery Technology Market Size by Application
  7. 3.2.1 Global Nasal Drug Delivery Technology Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Nasal Drug Delivery Technology Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Nasal Drug Delivery Technology Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Nasal Drug Delivery Technology Market Size by Regions
  11. 3.3.1 North America Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Nasal Drug Delivery Technology Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nasal Drug Delivery Technology Industry Trends
  2. 4.2 Nasal Drug Delivery Technology Industry Drivers
  3. 4.3 Nasal Drug Delivery Technology Industry Opportunities and Challenges
  4. 4.4 Nasal Drug Delivery Technology Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nasal Drug Delivery Technology Revenue (2021-2026)
  2. 5.2 Global Nasal Drug Delivery Technology Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nasal Drug Delivery Technology Key Company Headquarters & Area Served
  4. 5.4 Global Nasal Drug Delivery Technology Company, Product Type & Application
  5. 5.5 Global Nasal Drug Delivery Technology Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nasal Drug Delivery Technology Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nasal Drug Delivery Technology Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nasal Drug Delivery Technology Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Nasal Drug Delivery Technology Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Nasal Drug Delivery Technology Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Merck & Co., Inc.
  14. 6.3.1 Merck & Co., Inc. Company Information
  15. 6.3.2 Merck & Co., Inc. Business Overview
  16. 6.3.3 Merck & Co., Inc. Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co., Inc. Nasal Drug Delivery Technology Product Portfolio
  18. 6.3.5 Merck & Co., Inc. Recent Developments
  19. 6.4 Pfizer, Inc
  20. 6.4.1 Pfizer, Inc Company Information
  21. 6.4.2 Pfizer, Inc Business Overview
  22. 6.4.3 Pfizer, Inc Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer, Inc Nasal Drug Delivery Technology Product Portfolio
  24. 6.4.5 Pfizer, Inc Recent Developments
  25. 6.5 Shin Nippon Biomedical Laboratories
  26. 6.5.1 Shin Nippon Biomedical Laboratories Company Information
  27. 6.5.2 Shin Nippon Biomedical Laboratories Business Overview
  28. 6.5.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Portfolio
  30. 6.5.5 Shin Nippon Biomedical Laboratories Recent Developments
  31. 6.6 Promius Pharma, LLC
  32. 6.6.1 Promius Pharma, LLC Company Information
  33. 6.6.2 Promius Pharma, LLC Business Overview
  34. 6.6.3 Promius Pharma, LLC Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Promius Pharma, LLC Nasal Drug Delivery Technology Product Portfolio
  36. 6.6.5 Promius Pharma, LLC Recent Developments
  37. 6.7 PendoPharm, Inc
  38. 6.7.1 PendoPharm, Inc Company Information
  39. 6.7.2 PendoPharm, Inc Business Overview
  40. 6.7.3 PendoPharm, Inc Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 PendoPharm, Inc Nasal Drug Delivery Technology Product Portfolio
  42. 6.7.5 PendoPharm, Inc Recent Developments
  43. 6.8 OptiNose, Inc
  44. 6.8.1 OptiNose, Inc Company Information
  45. 6.8.2 OptiNose, Inc Business Overview
  46. 6.8.3 OptiNose, Inc Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 OptiNose, Inc Nasal Drug Delivery Technology Product Portfolio
  48. 6.8.5 OptiNose, Inc Recent Developments
  49. 6.9 Glaxosmithkline PLC
  50. 6.9.1 Glaxosmithkline PLC Company Information
  51. 6.9.2 Glaxosmithkline PLC Business Overview
  52. 6.9.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Product Portfolio
  54. 6.9.5 Glaxosmithkline PLC Recent Developments
  55. 6.10 ENT Technologies Pty. Ltd
  56. 6.10.1 ENT Technologies Pty. Ltd Company Information
  57. 6.10.2 ENT Technologies Pty. Ltd Business Overview
  58. 6.10.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Portfolio
  60. 6.10.5 ENT Technologies Pty. Ltd Recent Developments
  61. 6.11 Douglas Pharmaceuticals Ltd
  62. 6.11.1 Douglas Pharmaceuticals Ltd Company Information
  63. 6.11.2 Douglas Pharmaceuticals Ltd Business Overview
  64. 6.11.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
  66. 6.11.5 Douglas Pharmaceuticals Ltd Recent Developments
  67. 6.12 Dickinson and Company
  68. 6.12.1 Dickinson and Company Company Information
  69. 6.12.2 Dickinson and Company Business Overview
  70. 6.12.3 Dickinson and Company Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
  72. 6.12.5 Dickinson and Company Recent Developments
  73. 6.13 Cadila Pharmaceuticals Ltd
  74. 6.13.1 Cadila Pharmaceuticals Ltd Company Information
  75. 6.13.2 Cadila Pharmaceuticals Ltd Business Overview
  76. 6.13.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
  78. 6.13.5 Cadila Pharmaceuticals Ltd Recent Developments
  79. 6.14 BF Ascher & Company, Inc.
  80. 6.14.1 BF Ascher & Company, Inc. Company Information
  81. 6.14.2 BF Ascher & Company, Inc. Business Overview
  82. 6.14.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Portfolio
  84. 6.14.5 BF Ascher & Company, Inc. Recent Developments
  85. 6.15 Becton, Dickinson and Company
  86. 6.15.1 Becton, Dickinson and Company Company Information
  87. 6.15.2 Becton, Dickinson and Company Business Overview
  88. 6.15.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
  90. 6.15.5 Becton, Dickinson and Company Recent Developments
  91. 6.16 Aptargroup, Inc.
  92. 6.16.1 Aptargroup, Inc. Company Information
  93. 6.16.2 Aptargroup, Inc. Business Overview
  94. 6.16.3 Aptargroup, Inc. Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Aptargroup, Inc. Nasal Drug Delivery Technology Product Portfolio
  96. 6.16.5 Aptargroup, Inc. Recent Developments
  97. 6.17 Aegis Therapeutics LLC
  98. 6.17.1 Aegis Therapeutics LLC Company Information
  99. 6.17.2 Aegis Therapeutics LLC Business Overview
  100. 6.17.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Portfolio
  102. 6.17.5 Aegis Therapeutics LLC Recent Developments
  103. 6.18 3M United States
  104. 6.18.1 3M United States Company Information
  105. 6.18.2 3M United States Business Overview
  106. 6.18.3 3M United States Nasal Drug Delivery Technology Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 3M United States Nasal Drug Delivery Technology Product Portfolio
  108. 6.18.5 3M United States Recent Developments
7 North America
  1. 7.1 North America Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  3. 7.3 North America Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  3. 8.3 Europe Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  3. 10.3 South America Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nasal Drug Delivery Technology Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst